Psychedelic Medicine

Association

The neural basis of psychedelic action

Excerpts from the publication

Psychedelics are serotonin 2A receptor agonists that can lead to profound changes in perception, cognition and mood. In this review, we focus on the basic neurobiology underlying the action of psychedelic drugs. We first discuss chemistry, highlighting the diversity of psychoactive molecules and the principles that govern their potency and pharmacokinetics. We describe the roles of serotonin receptors and their downstream molecular signaling pathways, emphasizing key elements for drug discovery. We consider the impact of psychedelics on neuronal spiking dynamics in several cortical and subcortical regions, along with transcriptional changes and sustained effects on structural plasticity. Finally, we summarize neuroimaging results that pinpoint effects on association cortices and thalamocortical functional connectivity, which inform current theories of psychedelic action. By synthesizing knowledge across the chemical, molecular, neuronal, and network levels, we hope to provide an integrative perspective on the neural mechanisms responsible for the acute and enduring effects of psychedelics on behavior.

Read more

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments

Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychotic Symptoms

Could psychedelics be useful in the treatment of patients with personality disorder? A case report of psychotherapy with concomitant use of psychedelics

Cardiovascular safety of psychedelic medicine: current status and future directions

Psychedelic-Assisted Group Therapy: A Systematic Review

Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies